Market Dashboard
Rays of Belief Logo

Rays of Belief

Listed
MainboardBook Built Issue
Issue Price
₹227 to ₹239
Face Value
₹10 Per Equity Share
Issue Size
₹125 Cr.
Listing On
BSENSE
Live

Allotment Available

Check your individual allotment on the official registrar portal.

Check Allotment

Grey Market

₹15
+6.28% Est. Listing Premium
Est. Listing Price₹254
Updated: 07 Sept 2026, 23:36

About Rays of Belief IPO

Rays of Belief, started in 2017, is a for-profit social enterprise that offers customized intervention programs for children with Neurodevelopmental Disorders (NDDs). The conditions they help with are Autism Spectrum Disorder (ASD), ADHD, Down Syndrome, Cerebral Palsy, Intellectual Disability, Learning Disabilities, and Global Developmental Delays.

Financial Health

Period EndedRevenueAssetsPAT
2024₹30.76₹12.89₹0.85
2025₹36.54₹26.12₹5.88
2026₹82.06₹50.89₹4.96

Live Subscriptions

Tracking
Categoryday 1day 2day 3
qib0x0.01x9.06x
nii0.39x2.07x279.11x
bnii0.13x1.12x303.82x
snii0.9x3.98x229.7x
retail6.51x18.67x195.86x
Total1.18x3.63x107.71x

Frequently Asked Questions

The public subscription window officially opens on 01 September 2026 and concludes at 5:00 PM IST on 03 September 2026.
As of the latest market information, the GMP is ₹15, indicating a 6.28% estimated listing premium. GMP is an unofficial market indicator and can change rapidly.
Shares are offered at ₹227 to ₹239. Retail investors must bid for at least 62 shares, requiring a block investment of ₹14,818.
The allotment has been detected as available in the Kfin Technologies Ltd. system. You can use the official registrar link on this page to check your individual status. Shares are scheduled to debut on the exchanges on 08 September 2026.
The registrar for this IPO is Kfin Technologies Ltd..
The issue size for Rays of Belief is ₹125 Cr..
The current status of the Rays of Belief IPO is Listed. This status is determined from the issue and listing timeline using Indian Standard Time.
No. GMP is unofficial and can move significantly before listing. The actual listing price may differ from the GMP-based estimate.